tetano
Editor, Senior Moderator
Respir Med Case Rep
. 2020 May 31;30:101113.
doi: 10.1016/j.rmcr.2020.101113. eCollection 2020.
Successful Recovery From Critical COVID-19 Pneumonia With Extracorporeal Membrane Oxygenation: A Case Report
Yuichi Ikuyama[SUP] 1 [/SUP], Yosuke Wada[SUP] 1 [/SUP], Kazunari Tateishi[SUP] 1 [/SUP], Yoshiaki Kitaguchi[SUP] 1 [/SUP], Masanori Yasuo[SUP] 1 [/SUP], Atsuhito Ushiki[SUP] 1 [/SUP], Kazuhisa Urushihata[SUP] 1 [/SUP], Hiroshi Yamamoto[SUP] 1 [/SUP], Hiroshi Kamijo[SUP] 2 [/SUP], Atsuyoshi Mita[SUP] 2 [/SUP], Hiroshi Imamura[SUP] 2 [/SUP], Masayuki Hanaoka[SUP] 1 [/SUP]
Affiliations
Abstract
A public health emergency of current international concern is the outbreak of a severe respiratory illness, that is, coronavirus disease (COVID-19). The disease initially started in Wuhan, China, and it rapidly spread to most regions of the world. Herein, we report a case of critical COVID-19 pneumonia treated with extracorporeal membrane oxygenation from symptom onset day 19 (SOD#19) to SOD#30. We describe the patient's clinical course, from mild symptoms at the time of illness onset to symptoms of severe pneumonia as the illness progressed. We provide important information regarding our clinical experience for further understanding of management discrepancies, as treatment with extracorporeal membrane oxygenation or pharmacotherapy (e.g., antivirals, immunomodulators, and glucocorticoids) is often dependent on the severity of symptoms.
Keywords: ARDS, acute respiratory distress syndrome; Acute respiratory distress syndrome; COVID-19, coronavirus disease; Coronavirus; ECMO, extracorporeal membrane oxygenation; Gamma-globulin; IVIG, intravenous immune globulin; Organizing pneumonia; RT-PCR, reverse transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
. 2020 May 31;30:101113.
doi: 10.1016/j.rmcr.2020.101113. eCollection 2020.
Successful Recovery From Critical COVID-19 Pneumonia With Extracorporeal Membrane Oxygenation: A Case Report
Yuichi Ikuyama[SUP] 1 [/SUP], Yosuke Wada[SUP] 1 [/SUP], Kazunari Tateishi[SUP] 1 [/SUP], Yoshiaki Kitaguchi[SUP] 1 [/SUP], Masanori Yasuo[SUP] 1 [/SUP], Atsuhito Ushiki[SUP] 1 [/SUP], Kazuhisa Urushihata[SUP] 1 [/SUP], Hiroshi Yamamoto[SUP] 1 [/SUP], Hiroshi Kamijo[SUP] 2 [/SUP], Atsuyoshi Mita[SUP] 2 [/SUP], Hiroshi Imamura[SUP] 2 [/SUP], Masayuki Hanaoka[SUP] 1 [/SUP]
Affiliations
- PMID: 32523870
- PMCID: PMC7261438
- DOI: 10.1016/j.rmcr.2020.101113
Abstract
A public health emergency of current international concern is the outbreak of a severe respiratory illness, that is, coronavirus disease (COVID-19). The disease initially started in Wuhan, China, and it rapidly spread to most regions of the world. Herein, we report a case of critical COVID-19 pneumonia treated with extracorporeal membrane oxygenation from symptom onset day 19 (SOD#19) to SOD#30. We describe the patient's clinical course, from mild symptoms at the time of illness onset to symptoms of severe pneumonia as the illness progressed. We provide important information regarding our clinical experience for further understanding of management discrepancies, as treatment with extracorporeal membrane oxygenation or pharmacotherapy (e.g., antivirals, immunomodulators, and glucocorticoids) is often dependent on the severity of symptoms.
Keywords: ARDS, acute respiratory distress syndrome; Acute respiratory distress syndrome; COVID-19, coronavirus disease; Coronavirus; ECMO, extracorporeal membrane oxygenation; Gamma-globulin; IVIG, intravenous immune globulin; Organizing pneumonia; RT-PCR, reverse transcription polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.